Muriel Haim is a seasoned professional with over 30 years of experience in health economics, public affairs, and market access. Currently serving as a Board Member at NEOVACS SA and Genetika+, and holding the position of President at Fondation France Israël, Haim has also worked as a Market Access Consultant with expertise in the French market for diabetes, cardiovascular diseases, cancer, and respiratory illnesses. Previous roles include consultant positions with ESCULAPE INTERNATIONAL HEALTH, and director-level positions at Boehringer Ingelheim and Merck Group, along with significant contributions to Sanofi. Haim's educational background includes a Ph.D. in Health Economics from Université Paris Dauphine - PSL and a Doctor of Medicine from Université Paris 13.
This person is not in the org chart
This person is not in any teams
This person is not in any offices